Andrew Cluster
25 Papers
2 Citations
Andrew Cluster is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.
Isabel Arrillaga-Romany,Sharon L Gardner,Yazmin Odia,Dolly Aguilera,J. Allen,Tracy Batchelor,Nicholas Butowski,Clark C Chen,Timothy F. Cloughesy,Andrew Cluster,J. de Groot,Karan S Dixit,Jerome J Graber,Aya M Haggiagi,Rebecca A Harrison,Albert Kheradpour,Lindsay Kilburn,Sylvia C Kurz,Guangrong Lu,Tobey J. MacDonald,Minesh P. Mehta,A. S. Melemed,Phioanh L. Nghiemphu,Samuel Ramage,Nicole Shonka,Ashley Sumrall,Rohinton Tarapore,Lynne Taylor,Yoshie Umemura,Patrick Y Wen +29 more
TL;DR: ONC201 monotherapy was well tolerated and exhibited durable and clinically meaningful efficacy in recurrent H3 K27M-mutant DMG.
26
Multi-institutional study of the frequency, genomic landscape and outcome of IDH-mutant glioma in paediatrics.
Kee Kiat Yeo,Sanda Alexandrescu,Jennifer A. Cotter,Jayne Vogelzang,Varun Bhave,Marilyn M. Li,Jianling Ji,Jamal Benhamida,Marc K. Rosenblum,Tejus Bale,Nancy Bouvier,Kristiyana Kaneva,Tom Rosenberg,Mary Jane Lim Fat,Hia S. Ghosh,Migdalia Miranda Martínez,Dolly Aguilera,Amy Smith,Stewart Goldman,Eli L. Diamond,Igor T. Gavrilovic,Tobey J. MacDonald,Matthew D. Wood,Kellie J. Nazemi,Ai Lien Truong,Andrew Cluster,Keith L. Ligon,Kristina A. Cole,Wenya Linda Bi,Ashley Margol,Matthias A. Karajannis,Karen Wright +31 more
TL;DR: A subset of pediatric gliomas are driven by IDH1/2 mutations, with a higher rate among adolescents, and findings suggest that the natural history of children's glioma may be similar to that of adults, though additional studies are needed.
16
Prospective PTCTC Trial of Myeloablative HaploBMT with Post-transplant Cyclophosphamide for Pediatric Acute Leukemias.
Hua Ling Tsai,Amanda L. Blackford,Andrew Cluster,Emi Caywood,Jignesh Dalal,Jeffrey H. Davis,R. Maarten Egeler,Jeffrey S. Huo,Michelle Hudspeth,Amy E. Keating,Susan Kelly,Joerg Krueger,Dean A. Lee,Leslie Lehmann,Lisa Madden,Benjamin Oshrine,Michael A. Pulsipher,Terry J. Fry,Heather J. Symons +18 more
TL;DR: The first multicenter trial for pediatric and young adult patients with high-risk acute leukemias and myelodysplastic syndrome (MDS) in the US and Canada in the Pediatric Transplantation and Cellular Therapy Consortium (PTCTC) was reported in this paper .
12
LINC-08. Neuro-Oncology tumor board – one-year experience of international collaboration
Margaret Shatara,Evan Cantor,Ashley Meyer,Andrea Ogle,Kimberly Hofmann,T. Green,Mary Beck,Michele McHugh,Nicole M. Brossier,Andrew Cluster,Ali Mian,Sonika Dahiya,Zeyad Abdelaziz,Shady Fadel,Nahla Ali Mobark,Musa Alharbi,Soad K Aljaouni,Abrar Aljunaid,Waleed Said,Moatasem El-Ayadi,Madeha Mahmoud,Abeer Al-Battashi,Imen Chabchoub,Nisreen Khalifa,Nora F. Dengler,Pablo Hernáiz Driever,Nicolás Rojas del Río,Bożenna Dembowska-Bagińska,Marta Perek-Polnik,Szymon Skoczeń,Hetal Dholaria,Sumanth Nagabushan,M. Oliveira,Angela C. Hirbe,Amy E. Armstrong,David D. Limbrick,David H. Gutmann,Mohamed S. AbdelBaki +37 more
TL;DR: This initiative is expected to provide a platform for future international research collaborations and deliver the optimal medical care for neuro-oncology patients globally and promote a multi-disciplinary approach for the management of pediatric CNS tumors.
2
EPCT-07. Updated report on the pilot study of using MRI-guided laser heat ablation to induce disruption of the peritumoral blood brain barrier to enhance deliver and efficacy of treatment of pediatric brain tumors
Margaret Shatara,Karen Gauvain,Evan Cantor,Ashley Meyer,Andrea Ogle,Michele McHugh,Mary Beck,T. Green,Allison A. King,Andrew Cluster,Nicole M. Brossier,Joshua S. Shimony,Mohamed S. AbdelBaki,David Tran,Jian Campian,Eric C. Leuthardt,Joshua B. Rubin,David D. Limbrick +17 more
TL;DR: LITT is safe in children with brain tumors and can be combined with chemotherapy, and peritumoral BBB disruption was evident up to 4 months post-procedure.
2